Germany Phenylketonuria Market Size & Outlook, 2026-2034


Germany Phenylketonuria Market Insights

  • As per Reed Intelligence insights, the Germany Phenylketonuria Market stood at USD 71.42 Million in 2025 and is anticipated to grow to USD 128.12 Million by 2034.
  • The Germany market is expected to advance at a CAGR of 6.73% from 2026 through 2034.
  • In 2025, Enzyme Replacement Therapy accounted for the highest share of the By Treatment Type market size.
  • During the forecast period, Gene Therapy is set to register the highest growth, making it the most lucrative By Treatment Type segment.

Other Key Findings


  • In 2025, Germany represented 5.41% of the overall global Phenylketonuria Market size.
  • United States is projected to lead the global Phenylketonuria Market size by 2034.
  • Across Europe, Germany is anticipated to hold the dominant position in market size by 2034.
  • Germany is forecasted to expand at the fastest pace in Europe, attaining USD 128.35 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 71.42 Million
Market Size In 2034 USD 128.12 Million
Largest segment Enzyme Replacement Therapy
Units Revenue in USD Million
CAGR 6.73% (2026-2034)
Segmnetation Covered
By Treatment Type
  1. Enzyme Replacement Therapy
  2. Gene Therapy
  3. Medication
  4. Dietary Therapy
By Diagnosis
  1. Genetic Testing
  2. Biochemical Testing
  3. Newborn Screening
By End-User
  1. Specialty Clinics
  2. Research Institutes
  3. Home Healthcare
  4. Hospitals
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends